´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ APSCVIR 2023 2ÀÏÂ÷ (The 17th Annual Scientic Meeting of Asia Pacific Society of Cardiovascular and Interventional Radiology) : 2023-04-13
±³À°ÀÏÀÚ : 2023-04-13
±³À°Àå¼Ò : ÄÚ¿¢½º ±×·£µåº¼·ë 103È£ ¿Ü 4°³·ë
±³À°ÁÖÁ¦ : APSCVIR 2023 2ÀÏÂ÷ (The 17th Annual Scientic Meeting of Asia Pacific Society of Cardiovascular and Interventional Radiology)
ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ : office@intervention.or.kr
±³À°Á¾·ù : ¿µ»óÀÇÇаú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 26 ½Ã°£ 18ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Early Bird: Á¤È¸¿ø 150000¿ø, °£È£»ç, ¹æ»ç¼±»ç 50,000¿ø, Àü°øÀÇ.±ºÀÇ°ü.°øÁߺ¸°ÇÀÇ 100,000¿ø, Àü¹®ÀÇ 200,000¿ø / Regular: Á¤È¸¿ø 200000¿ø, °£È£»ç, ¹æ»ç¼±»ç 70,000¿ø, Àü°øÀÇ.±ºÀÇ°ü.°øÁߺ¸°ÇÀÇ 120,000¿ø, Àü¹®ÀÇ 250,000¿ø, Çлý ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 07:40~08:00 Tips and Tricks : Onyx-LES for TypeII Endoleak Management Joon Ho Kwon(Severance Hospital, Korea)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 08:00~08:10 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 08:30~08:45 TEVAR for uncomplicated type B aortic dissection: Is it really necessary? Constantino Peña(Miami Cardiac and Vascular Institute, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 08:45~09:00 Malperfusion in acute type B aortic dissection: Endovascular strategies Andrew Holden(Auckland City Hospital, New Zealand)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 09:00~09:15 Fenestrated and branched stent-grafts for TAAA Ming-Yi Hsu(Chang Gung Memorial Hospital, Taiwan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 09:15~09:30 Hybrid treatment of TAAA Suk Won Song(Gangnam Severance Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 09:30~09:45 How to prevent SINE and retrograde dissection after TEVAR Joon Ho Kwon(Severance Hospital, Korea)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 09:45~10:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 10:30~10:45 How to succeed EVAR for AAA with a hostile neck Norio Hongo(Oita University, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 10:45~11:00 Bilateral iliac artery aneurysms: Staged embolization or branched devices? Parag Patel(Froedtert Hospital, Medical College of Wisconsin, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 11:00~11:15 Type 1 endoleak: Treatment options and techniques Sung-Yu Chu(Chang Gung Memorial Hospital-Linkou, Taiwan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 11:15~11:30 Type 2 endoleak: When and how do we treat it? Joon Ho Kwon(Severance Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 11:30~11:45 Long-term outcomes of EVAR: How does it compare to open repair? Masato Yamaguchi(Kobe University Hospital, Japan)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 11:45~12:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 12:00~12:15 Covera : The Next Gold Standard in AV Stenting Uei Pua(Tan Tock Seng Hospital, Singapore)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 12:15~12:30 Initial experience with Covera stent graft in recalcitrant AV Access stenosis Ki Chang Han(Severance Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 13:30~13:45 Update on drug-eluting devices for lower limb arterial disease Robert Morgan(St. George)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 13:45~14:00 Transarterial treatment of acute ischemic stroke - How far have we come in 2023? Klaus Hausegger(Klagenfurt am Wörthersee, Austria)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 14:00~14:15 Liver regeneration strategies prior to major hepatectomies: An update Tiago Bilhim(Hospitalar Universitário de Lisboa Central, Portugal)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 14:15~14:30 Update on the European Board of Interventional Radiology (EBIR) Robert Morgan(St. George)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 14:30~14:40 CVIR: Tips for reviewing manuscripts Tiago Bilhim(Hospitalar Universitário de Lisboa Central, Portugal)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 14:40~14:50 Why are manuscripts rejected - The experience of the CVIR Editor-in-Chief Klaus Hausegger(Klagenfurt am Wörthersee, Austria)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 14:50~15:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 15:30~15:45 Thrombectomy devices for acute DVT Auh Whan Park(UT Southwestern Medical Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 15:45~16:00 Acute pulmonary embolism and DVT team in the US Edward Lee(UCLA Medical Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 16:00~16:15 How to diagnose and treat of NIVL(non-thrombotic iliac vein lesion)? Uei Pua(Tan Tock Seng Hospital, Singapore)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 16:15~16:30 Chronic venous recanalization techniques and outcomes Gerard O(Galway University Hospital, Ireland)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 16:30~16:45 IVC filter program and retrieval issues Jung Guen Cha(Kyungpook National University, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 103 16:45~17:00 New anticoagulants for prophylaxis and treatment of DVT Jang Yong Kim(The Catholic University of Korea, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 08:30~08:45 IR Jin Wook Chung(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 08:45~09:00 cTACE or DEB-TACE: Oldies, but goodies? Yasuaki Arai(National Cancer Center, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 09:00~09:15 Do chemodrugs have a role in TACE?: Never-ending debate Jin Woo Choi(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 09:15~09:30 Can Y90 compete with ablation for small HCC? Edward Kim(Mount Sinai Medical Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 09:30~09:45 Radioembolization of mCRC: Is it good enough? Siddharth Padia(University of California Los Angeles, USA)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 09:45~10:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 10:30~10:45 Clinical updates in radioembolization for HCC Edward Kim(Mount Sinai Medical Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 10:45~11:00 Future Directions of Radioembolization Nima Kokabi(Emory University, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 11:00~11:15 Approach to palliative ablation in the head and neck Uei Pua(Tan Tock Seng Hospital, Singapore)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 11:15~11:30 Irreversible electroporation: what Huang Kai-wen(National University Hospital of Taiwan, Taiwan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 11:30~11:45 Advanced ablation for palliation Sean Tutton(University Of California, San Diego, USA)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 11:45~12:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 13:30~13:45 RFA of benign thyroid disease Auh Whan Park(UT Southwestern Medical Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 13:45~14:00 RFA of malignant thyroid disease So Lyung Jung(Yeouido St. Mary)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 14:00~14:15 Ablation therapy for small renal cell carcinoma Sung Il Hwang(Seoul National University Bundang Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 14:15~14:30 Ablation for adrenal tumor: Indication and technique Byung Kwan Park(Samsung Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 14:30~14:45 Ablation therapy for lung metastasis Hyun Pyo Hong(Kangbuk Samsung Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 14:45~15:00 Ablation therapy of bone tumor Alda Tam(M.D. Anderson Cancer Center, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 15:30~15:45 What should we consider for chosing treatment modality? Dong Hyun Sinn(Samsung Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 15:45~16:00 Update in liver surgery for very early stage HCC Jongman Kim(Samsung Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 16:00~16:15 Thermal ablation therapy for very early stage HCC Dong Ho Lee(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 16:15~16:30 Cryoablation for very early stage HCC Chengli Li(Shandong University, China)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 16:30~16:45 Transarterial therapy for very early stage HCC Nutcha Pinjaroen(Chulalongkorn University, Thailand)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 104 16:45~17:00 Radiation therapy for very early stage HCC Jinhong Jung(Asan Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 08:30~08:45 Role of IR in trauma activation Hiroshi Kondo(Teikyo University School of Medicine, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 08:45~09:00 CEUS for trauma patient Yook Kim(Chungbuk National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 09:00~09:15 Trauma intervention for pelvic injury Tae Won Choi(Ajou University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 09:15~09:30 Splenic artery embolization in trauma Gerard Goh(The Alfred Hospital, Australia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 09:30~09:45 Trauma intervention for peripheral vascular injury Jeong Ho Kim(Gachon University Gil Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 09:45~10:00 Blunt aortic injury Masato Yamaguchi(Kobe University Hospital, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 10:30~10:45 New liquid embolic agents Gerard Goh(The Alfred Hospital, Australia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 10:45~11:00 New coils and particulates Apoorva Gogna(Singapore General Hospital, Singapore)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 11:00~11:15 Steerable microcatheter Yoshitaka Inaba(Aichi Cancer Center Hospital, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 11:15~11:30 Balloon microcatheter Terumitsu Hasebe(Tokai University Hachioji Hospital, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 11:30~11:45 Interventional robot: Next-generation platform? Satoshi Tateshima(University of California at Los Angeles, USA)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 11:45~12:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 13:30~13:45 The angiosome theory: Just a theory? Shigeo Ichihashi(Nara Medical University, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 13:45~14:00 The CTO toolbox Je Hwan Won(Ajou University Hopsital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 14:00~14:15 Retrograde access for infrapopliteal intervention Tomoyasu Sato(Tsuchiya General Hospital, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 14:15~14:30 Beyond POBA for tibial intervention: Where does DCB and DES stand? Farah Gillan Irani(Singapore General Hospital, Singapore)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 14:30~14:45 Percutaneous deep venous arterialization: an option for no-option CLI? Marco Manzi(Policlinico Abano Terme, Italy)
Åä·Ð 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 14:45~15:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 15:30~15:45 Generalized lymphatic anomaly and Gorham disease Lakshmi Ratnam(St. George)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 15:45~16:00 Pulmonary lymphatic perfusion syndrome Claus Christian Pieper(University Hospital Bonn, Germany)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 16:00~16:15 Primary chylous reflux disease and Noonan syndrome Saebeom Hur(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 16:15~16:30 Protein-losing enteropathy as a complication of Fontan circulation Maxim Itkin(University of Pennsylvania, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 16:30~16:45 Role of medical therapy in lymphatic disease Kyung Taek Hong(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ±×·£µåº¼·ë 105 16:45~17:00 Lymphovenous shunt surgery: when and how Hak Chang(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 08:30~08:45 Endovascular treatment of AIS: Overview Woong Yoon(Chonnam National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 08:45~09:00 Current topics in AIS intervention Jeyaledchumy Mahadevan(Hospital Pantai Kuala Lumpur, Malaysia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 09:00~09:15 CAS: Overview and current topics Takayama Katsutoshi(Kouseikai Takai Hospital, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 09:15~09:30 Case discussion: Acute ischemic stroke Alex Tang(Subang Jaya Medical Centre, Malaysia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 09:30~09:45 Case discussion: Chronic ischemic stroke Deok Hee Lee(Asan Medical Center, Korea)
Åä·Ð 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 09:45~10:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 10:30~10:45 Endovascular treatment for cerebral aneurysm: Overview Sangil Suh(Korea University Guro Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 10:45~11:00 Current topics in neurointervention for cerebral aneurysm Hae Woong Jeong(Inje University Busan Paik Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 11:00~11:15 Endovascular treatment of Brain AVMs: Overview and current topics Jeyaledchumy Mahadevan(Hospital Pantai Kuala Lumpur, Malaysia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 11:15~11:30 Case discussion: Aneurysm Byungjun Kim(Korea University Anam Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 11:30~11:45 Case discussion: AVM Shuichi Tanoue(Kurume University, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 11:45~12:00 Case discussion: Dural AVFs Hiro Kiyosue(Kumamoto University, Japan)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 13:30~13:45 Mechanism of Action Jin Woo Choi(Seoul National University Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 13:45~14:00 GAE: Where does it stand? Siddharth Padia(University of California Los Angeles, USA)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 14:00~14:15 Genicular artery embolization for recurrent hemarthrosis Christopher Rogan(Royal Prince Alfred Hospital, Australia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 14:15~14:30 Embolic agents for MSK embolization Sang Woo Park(Konkuk University Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 14:30~14:45 MSK embolization other than GAE Yuji Okuno(Okuno Clinic, Japan)
Åä·Ð 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 14:45~15:00 Discussion ()
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 15:30~15:45 Nonvascular embolization for urinary leaks Ji Hoon Shin(Asan Medical Center, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 15:45~16:00 Recanalization of urinary obstruction: Technical tips Gunawan Santoso(Universitas Diponegoro-Dr. Kariadi Hospital Semarang, Indonesia)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 16:00~16:15 Interventional management of complicated kidney transplantation Ho Jong Chun(Seoul St. Mary)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 16:15~16:30 Percutaneous lung biopsy: Optimizing yield and mitigating risk Somrach Thamtorawat(Siriraj Hospital, Thailand)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 16:30~16:45 Nonvascular embolization for pulmonary fistulas David Yurui Lim(Changi General Hospital, Singapore)
Åä·Ð 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 201 16:45~17:00 Discussion ()
±âŸ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 10:30~10:35 Welcome by the speakers Klaus Hausegger(Klagenfurt am Wörthersee, Austria)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 10:35~11:00 How to improve you paper? Chang Jin Yoon(Seoul National University Bundang Hospital, Korea)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 11:00~11:25 International reporting guidelines, and structuring your manuscript Tiago Bilhim(Hospitalar Universitário de Lisboa Central, Portugal)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 11:25~11:50 How to define a valid research question and topic? Klaus Hausegger(Klagenfurt am Wörthersee, Austria)
±³À°½Ã°£ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 11:50~11:53 Video: presenting CVIR Endovascular Jim Reekers(Amsterdam University, Netherlands)
±âŸ 04-13 ÄÚ¿¢½º ÄÁÆÛ·±½º·ë 203 11:53~12:00 Q&A and closing remarks ()